Cyclosporine A to Treat Unexplained Recurrent Spontaneous Abortions: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Single-Center Trial

References

• Fainboim L, Belén S, González V, Fernández P. Evaluation of paternal lymphocyte immunotherapy and potential biomarker mixed lymphocyte reaction-blocking factor in an Argentinian cohort of women with unexplained recurrent spontaneous abortion and unexplained infertility. Am J Reprod Immunol. 2021;86(2):e13422. doi:10.1111/aji.13422
   Web of Science ®Google Scholar
• Li TY, Li R, Zeng L, et al. In vitro fertilization-embryo transfer in patients with unexplained recurrent pregnancy loss. Chin Med J. 2021;134(20):2421–2429. doi:10.1097/cm9.0000000000001657
   Web of Science ®Google Scholar
• Grandone E, Tiscia GL, Mastroianno M, et al. Findings from a multicentre, observational study on reproductive outcomes in women with unexplained recurrent pregnancy loss: the OTTILIA registry. Hum Reprod. 2021;36(8):2083–2090. doi:10.1093/humrep/deab153
   Web of Science ®Google Scholar
• Ahmadi M, Abdolmohammadi-Vahid S, Ghaebi M, et al. Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL). Biomed Pharmacother. 2017;92:1095–1102. doi:10.1016/j.biopha.2017.06.001
   Web of Science ®Google Scholar
• Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98(5):1103–1111. doi:10.1016/j.fertnstert.2012.06.048
   PubMed Web of Science ®Google Scholar
• Shahine L, Lathi R. Recurrent pregnancy loss: evaluation and treatment. Obstet Gynecol Clin North Am. 2015;42(1):117–134. doi:10.1016/j.ogc.2014.10.002
   PubMed Web of Science ®Google Scholar
• Rasmussen SA, Kelley CF, Horton JP, Jamieson DJ. Coronavirus disease 2019 (COVID-19) vaccines and pregnancy: what obstetricians need to know. Obstet Gynecol. 2021;137(3):408–414. doi:10.1097/aog.0000000000004290
   PubMed Web of Science ®Google Scholar
• Zeng W, Liu Z, Liu X, et al. Distinct transcriptional and alternative splicing signatures of decidual CD4(+) T cells in early human pregnancy. Front Immunol. 2017;8:682. doi:10.3389/fimmu.2017.00682
   PubMed Web of Science ®Google Scholar
• Peng Y, Yin S, Wang M. Significance of the ratio interferon-γ/interleukin-4 in early diagnosis and immune mechanism of unexplained recurrent spontaneous abortion. Int J Gynaecol Obstet. 2021;154(1):39–43. doi:10.1002/ijgo.13494
   Web of Science ®Google Scholar
• Chen HY, Li OY, Pang LH, et al. Expression of FK506-binding protein 52 (FKBP52) in chorionic villi with early recurrent spontaneous abortion. J Matern Fetal Neonatal Med. 2015;28(10):1165–1169. doi:10.3109/14767058.2014.947572
   PubMed Web of Science ®Google Scholar
• Kwak-Kim JY, Chung-Bang HS, Ng SC, et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod. 2003;18(4):767–773. doi:10.1093/humrep/deg156
   PubMed Web of Science ®Google Scholar
• Crome SQ, Wang AY, Levings MK. Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol. 2010;159(2):109–119. doi:10.1111/j.1365-2249.2009.04037.x
   PubMed Web of Science ®Google Scholar
• Jutel M, Akdis M, Budak F, et al. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol. 2003;33(5):1205–1214. doi:10.1002/eji.200322919
   PubMed Web of Science ®Google Scholar
• Hosseini A, Dolati S, Hashemi V, Abdollahpour-Alitappeh M, Yousefi M. Regulatory T and T helper 17 cells: their roles in preeclampsia. J Cell Physiol. 2018;233(9):6561–6573. doi:10.1002/jcp.26604
   PubMed Web of Science ®Google Scholar
• Muyayalo KP, Li ZH, Mor G, Liao AH. Modulatory effect of intravenous immunoglobulin on Th17/Treg cell balance in women with unexplained recurrent spontaneous abortion. Am J Reprod Immunol. 2018;80(4):e13018. doi:10.1111/aji.13018
   Web of Science ®Google Scholar
• Sheu A, Chan Y, Ferguson A, et al. A proinflammatory CD4(+) T cell phenotype in gestational diabetes mellitus. Diabetologia. 2018;61(7):1633–1643. doi:10.1007/s00125-018-4615-1
   Web of Science ®Google Scholar
• Zaffar N, Soete E, Gandhi S, Sayyar P, Van Mieghem T, D’Souza R. Pregnancy outcomes following single and repeat liver transplantation: an international 2-center cohort. Liver Transpl. 2018;24(6):769–778. doi:10.1002/lt.25071
   Web of Science ®Google Scholar
• Zhou WH, Dong L, Du MR, Zhu XY, Li DJ. Cyclosporin A improves murine pregnancy outcome in abortion-prone matings: involvement of CD80/86 and CD28/CTLA-4. Reproduction. 2008;135(3):385–395. doi:10.1530/rep-07-0063
   PubMed Web of Science ®Google Scholar
• Du MR, Dong L, Zhou WH, Yan FT, Li DJ. Cyclosporin a improves pregnancy outcome by promoting functions of trophoblasts and inducing maternal tolerance to the allogeneic fetus in abortion-prone matings in the mouse. Biol Reprod. 2007;76(5):906–914. doi:10.1095/biolreprod.106.056648
   Web of Science ®Google Scholar
• Archer TM, Stokes JV, Kummari E, et al. In vivo effects of aspirin and cyclosporine on regulatory T cells and T-cell cytokine production in healthy dogs. Vet Immunol Immunopathol. 2018;197:63–68. doi:10.1016/j.vetimm.2018.01.003
   Web of Science ®Google Scholar
• Azizi R, Ahmadi M, Danaii S, et al. Cyclosporine A improves pregnancy outcomes in women with recurrent pregnancy loss and elevated Th1/Th2 ratio. J Cell Physiol. 2019;234(10):19039–19047. doi:10.1002/jcp.28543
   PubMed Web of Science ®Google Scholar
• Ling Y, Huang Y, Chen C, Mao J, Zhang H. Low dose Cyclosporin A treatment increases live birth rate of unexplained recurrent abortion - initial cohort study. Clin Exp Obstet Gynecol. 2017;44(2):230–235.
   Web of Science ®Google Scholar
• Wang S, Li M, Sun F, et al. Th17/Treg-cell balance in the peripheral blood of pregnant females with a history of recurrent spontaneous abortion receiving progesterone or cyclosporine A. Exp Ther Med. 2021;21(1):37. doi:10.3892/etm.2020.9469
   Web of Science ®Google Scholar
• Fu JH. Analysis of the use of cyclosporin A to treat refractory immune recurrent spontaneous abortion. Clin Exp Obstet Gynecol. 2015;42(6):739–742.
   Web of Science ®Google Scholar
• Jiang F, Hu X, Jiang K, Pi H, He Q, Chen X. The role of low molecular weight heparin on recurrent pregnancy loss: a systematic review and meta-analysis. Taiwan J Obstet Gynecol. 2021;60(1):1–8. doi:10.1016/j.tjog.2020.11.001
   Web of Science ®Google Scholar
• Pasquier E, de Saint-martin L, Marhic G, et al. Hydroxychloroquine for prevention of recurrent miscarriage: study protocol for a multicentre randomised placebo-controlled trial BBQ study. BMJ Open. 2019;9(3):e025649. doi:10.1136/bmjopen-2018-025649
   PubMed Web of Science ®Google Scholar
• Blomqvist L, Hellgren M, Strandell A. Acetylsalicylic acid does not prevent first-trimester unexplained recurrent pregnancy loss: a randomized controlled trial. Acta Obstet Gynecol Scand. 2018;97(11):1365–1372. doi:10.1111/aogs.13420
   PubMed Web of Science ®Google Scholar
• Huang W, Lu W, Li Q, et al. Effects of cyclosporine A on proliferation, invasion and migration of HTR-8/SVneo human extravillous trophoblasts. Biochem Biophys Res Commun. 2020;533(4):645–650. doi:10.1016/j.bbrc.2020.09.072
   Web of Science ®Google Scholar